(Q42629673)

4 November 2017

title

Oral R115866 in the treatment of moderate to severe plaque-type psoriasis (English)

1 reference

4 November 2017

Verfaille CJ

1

1 reference

4 November 2017

Thissen CA

2

1 reference

4 November 2017

Bovenschen HJ

3

1 reference

4 November 2017

Mertens J

4

1 reference

4 November 2017

Steijlen PM

5

1 reference

4 November 2017

van de Kerkhof PC

6

1 reference

4 November 2017

publication date

1 September 2007

1 reference

Journal of the European Academy of Dermatology and Venereology

4 November 2017

published in

1 reference

4 November 2017

volume

21

1 reference

4 November 2017

issue

8

1 reference

4 November 2017

page(s)

1038-1046

1 reference

Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

21 January 2018

Retinoic acid metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Exposure to retinyl esters, retinol, and retinoic acids in non-pregnant women following increasing single and repeated oral doses of vitamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Treatment of psoriasis with oral liarozole: a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Serum lipid levels in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Plasma Delivery of Retinoic Acid to Tissues in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

The pharmacology and pharmacokinetics of the retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Adverse effects of retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02158.X

10.1111/J.1468-3083.2007.02158.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference